Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Liver Diseases

Free Subscription 01.12.2025 1 Biochem Biophys Res Commun 4 BMC Cancer 3 BMC Gastroenterol 2 Endoscopy 1 Eur Radiol 2 Int J Cancer 3 J Hepatol 1 J Pediatr Surg 3 Lancet 2 PLoS One 1 Proc Natl Acad Sci U S A 2 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biochem Biophys Res Commun

1. KONISHI K, Mochimaru Y, Matsumoto A, Katagiri K, et al
   Unconventional protein secretion of La/SSB in liver cancer.
   Biochem Biophys Res Commun. 2025;791:152949.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. YUAN J, Pan Z, Lv F, Zhao Y, et al
   Transcription factor FOXC2 regulates miR-145/ADAMTS5 axis to inhibit angiogenesis in hepatocellular carcinoma via circular RNA 0002898.
   BMC Cancer. 2025;25:1814.
   PubMed         Abstract available
   
   
3. ZHENG Q, Chen S, Weng J, Huang H, et al
   Can the detection of serum glutathione reductase serve as an effective complement to traditional tumor biomarkers in clinical laboratory medicine for patients with hepatocellular carcinoma?
   BMC Cancer. 2025 Nov 26. doi: 10.1186/s12885-025-15383.
   PubMed         Abstract available
   
   
4. ZHANG Z, Dou H, Zhao S, Wang J, et al
   Single-cell multi-omics analysis reveals drivers of intrahepatic cholangiocarcinoma metastasis.
   BMC Cancer. 2025 Nov 24. doi: 10.1186/s12885-025-15253.
   PubMed        
   
   
5. CHAIGNEAU T, Dejardin O, Nguyen TTN, Bouvier AM, et al
   The socioeconomic environment and access to care affect the survival of patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
   BMC Cancer. 2025 Nov 21. doi: 10.1186/s12885-025-15174.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

6. LIU Z, Ke B, Tan S, Zhang Z, et al
   Role of non-invasive serological and CT imaging parameters in assessing portal hypertensive gastropathy severity.
   BMC Gastroenterol. 2025;25:840.
   PubMed         Abstract available
   
   
7. FUJII H, Nishimura T, Kimura H, Mitsumoto Y, et al
   A novel scoring system to identify patients at low risk for hepatocellular carcinoma five years after DAA-Induced sustained virological response: a retrospective cohort study.
   BMC Gastroenterol. 2025;25:835.
   PubMed         Abstract available
   
   
8. ZHENG Z, Shen Y, Min HC, Peng H, et al
   Risk factors and prediction model development for pancreatic fistula following splenectomy in Wilson's disease patients with portal hypertension.
   BMC Gastroenterol. 2025 Nov 25. doi: 10.1186/s12876-025-04475.
   PubMed        
   
   

   
   Endoscopy

9. MATSUBARA S, Arai T, Sunada R, Nakagawa K, et al
   Salvage transmural lithotripsy via endoscopic ultrasound-guided hepaticogastrostomy for basket impaction in Roux-en-Y anatomy.
   Endoscopy. 2025;57.
   PubMed        
   
   
10. FUJII Y, Matsumoto K, Uchida D, Horiguchi S, et al
    Antegrade enteral stenting for afferent loop syndrome using the double-guidewire technique via endoscopic ultrasound-guided hepaticogastrostomy.
    Endoscopy. 2025;57.
    PubMed        
    
    

    
    Eur Radiol

11. PAN YJ, Chen LL, Wang Z, Lin J, et al
    A prospective study of tumor-stroma ratio in resected intrahepatic mass-forming cholangiocarcinoma: prognostic value and correlation with gadoxetic acid-enhanced MRI.
    Eur Radiol. 2025 Nov 27. doi: 10.1007/s00330-025-12169.
    PubMed         Abstract available
    
    

    
    Int J Cancer

12. ZAHEDIAN A, Hejazian E, Barary M, Ranaee M, et al
    Comments on "Plant-based diet index and risk of hepatocellular carcinoma: Findings from a prospective cohort study".
    Int J Cancer. 2025 Nov 28. doi: 10.1002/ijc.70242.
    PubMed        
    
    
13. PHAM YT, Yuan JM, Luu HN
    Reply to 'Comment on "Plant-based diet index and risk of hepatocellular carcinoma: Findings from a prospective cohort study"'.
    Int J Cancer. 2025 Nov 28. doi: 10.1002/ijc.70241.
    PubMed        
    
    

    
    J Hepatol

14. AGUILAR F, Lozano JJ, Claria J, Reinartz Groba SN, et al
    Maladaptive emergency granulopoiesis predicts poor outcomes in patients hospitalized with decompensated cirrhosis.
    J Hepatol. 2025 Nov 26:S0168-8278(25)02630-3. doi: 10.1016/j.jhep.2025.
    PubMed         Abstract available
    
    
15. CORDIER P, Hirsch TZ, Caruso S, Pan L, et al
    Intratumour Ploidy Heterogeneity and Clonal Evolution in Hepatocellular Carcinoma.
    J Hepatol. 2025 Nov 24:S0168-8278(25)02654-6. doi: 10.1016/j.jhep.2025.
    PubMed         Abstract available
    
    
16. DING K, Mao A, Wang Y, Ni Z, et al
    MARCO(+) macrophages drive immunosuppressive remodeling and metastasis in chemotherapy-associated steatohepatitis.
    J Hepatol. 2025 Nov 20:S0168-8278(25)02624-8. doi: 10.1016/j.jhep.2025.
    PubMed         Abstract available
    
    

    
    J Pediatr Surg

17. FUCHS J, Hery G, Ruping F, Fouquet V, et al
    Surgical Outcomes of Liver Resection for Hepatoblastoma in Infants Versus Older Children: A Bi-Centric, Propensity-Score-Matched, Comparative Study.
    J Pediatr Surg. 2025 Nov 20:162824. doi: 10.1016/j.jpedsurg.2025.162824.
    PubMed         Abstract available
    
    

    
    Lancet

18. GALLE PR, Yau T, Decaens T
    Treatments for unresectable hepatocellular carcinoma: insights from CheckMate 9DW - Authors' reply.
    Lancet. 2025;406:2423-2424.
    PubMed        
    
    
19. SHI R, Li J, Zhang L
    Treatments for unresectable hepatocellular carcinoma: insights from CheckMate 9DW.
    Lancet. 2025;406:2422-2423.
    PubMed        
    
    
20. SANTHOSH A, Sreenath ND
    Treatments for unresectable hepatocellular carcinoma: insights from CheckMate 9DW.
    Lancet. 2025;406:2421-2422.
    PubMed        
    
    

    
    PLoS One

21. MAO YY, Zhang K, Zhao DD, Cui JW, et al
    Combining transcriptomics with network pharmacology to explore the mechanism of Yiqi Huoxue decoction against liver fibrosis.
    PLoS One. 2025;20:e0337061.
    PubMed         Abstract available
    
    
22. SAAD ZM, Keryakos HKH, Hassanin HA, Higazi MM, et al
    MAFLD in Egyptian non-dialysis CKD Patients: Frequency, fibrosis severity, and risk factors.
    PLoS One. 2025;20:e0336568.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

23. ANGELES-SOLANO M, Tabashsum Z, Liu JD, Lifschin ZJ, et al
    Antibiotics accumulate in Klebsiella pneumoniae liver abscesses but fail to eliminate antibiotic-tolerant populations.
    Proc Natl Acad Sci U S A. 2025;122:e2524436122.
    PubMed         Abstract available
    
    

    
    Radiology

24. YU SCH, Chan L, Lee KF, Cho CCM, et al
    Ethiodized Oil-based Transarterial Chemoembolization for Hepatocellular Carcinoma: Randomized Clinical Trial of Anhydrous Cisplatin Suspension versus Cisplatin Emulsion.
    Radiology. 2025;317:e242982.
    PubMed         Abstract available
    
    
25. PARK R, Choi ES, Byun JH, Won HJ, et al
    Diagnostic Value of Precontrast Low Attenuation as a LI-RADS CT Ancillary Feature for Hepatocellular Carcinoma.
    Radiology. 2025;317:e251598.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.